Product Code: A74579
The global microbial cellulose market was valued at $20.7 million in 2022, and is projected to reach $64.5 million by 2032, growing at a CAGR of 12.2% from 2023 to 2032.
Microbial cellulose or bacterial cellulose is a natural biomaterial produced by bacteria. Also, microbial cellulose with various morphologies and physiochemical properties can be made by adding nanoparticles, polymers, and other components to the culture media. Consequently, microbial cellulose is a sustainable and highly competitive alternative to plant-based cellulose nanofibers.
Further, microbial cellulose possesses a special structure of cellulose nanofiber-weaved 3D reticulated network. It has superior mechanical properties, exceptional suspension stability, and high water-holding capability. Besides, microbial cellulose has a high degree of crystallinity, high purity, and excellent biocompatibility and biodegradability. Owing to these benefits, microbial cellulose has achieved significant traction in both academic as well as industrial areas such as food, textile, household chemicals, personal care, biomedicine, composite resin, and others.
For the purpose of analysis, the microbial cellulose market scope covers segmentation based on growth medium, application, and region. The report provides information on the growth medium segment including synthetic and natural. Furthermore, the major applications covered in the study include food & beverage, medical, cosmetics & personal care, paper, textile, and others. In addition, it analyzes the current market trends across different regions such as North America, Europe, Asia-Pacific, and LAMEA.
The growth drivers, restraints, and opportunities are explained in the report to better understand the market dynamics. This report further highlights the key areas of investment. In addition, it includes Porter's five forces analysis to understand the competitive scenario of the industry and the role of each stakeholder. Value chain analysis for this industry, which includes R&D, components manufacturers, assembly, programming & testing, marketing & sales, customers, and post-sales services, is explained. The report features the strategies adopted by key market players to maintain their foothold in the market. Furthermore, it highlights the competitive landscape of the key players to increase their market share and sustain the intense competition in the industry.
In addition, the report covers profiles of key industry participants such as Ashland, Axcelon Biopolymers Corporation, BacPolyZyme, BIOESQUE, Borregaard AS, BOWIL Biotech Sp. z o.o., HBBE, HNB BIO CO., LTD, HYSSES, and Merck KGaA.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the microbial cellulose market analysis from 2022 to 2032 to identify the prevailing microbial cellulose market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the microbial cellulose market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global microbial cellulose market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Growth Medium
By Application
- Cosmetics and Personal Care
- Paper
- Textile
- Others
- Food and Beverage
- Medical
By Region
- North America
- Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa,
- Saudi Arabia
- Rest of LAMEA
Key Market Players:
- Ashland
- Axcelon Biopolymers Corporation
- BacPolyZyme
- BIOESQUE
- Borregaard AS
- BOWIL Biotech Sp. z o.o.
- HBBE
- HNB BIO CO., LTD.
- HYSSES
- Merck KGaA
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter's five forces analysis
- 3.3.1. Bargaining power of suppliers
- 3.3.2. Bargaining power of buyers
- 3.3.3. Threat of substitutes
- 3.3.4. Threat of new entrants
- 3.3.5. Intensity of rivalry
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Growth in demand for microbial cellulose from food & beverage sector
- 3.4.1.2. Increasing use of microbial cellulose in healthcare industry
- 3.4.2. Restraints
- 3.4.2.1. Higher cost associated with microbial cellulose production
- 3.4.3. Opportunities
- 3.4.3.1. Growing demand for personal care ingredients and products
- 3.5. COVID-19 Impact Analysis on the market
- 3.6. Patent Landscape
CHAPTER 4: MICROBIAL CELLULOSE MARKET, BY GROWTH MEDIUM
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Synthetic
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Natural
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
CHAPTER 5: MICROBIAL CELLULOSE MARKET, BY APPLICATION
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Food and Beverage
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Medical
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.4. Cosmetics and Personal Care
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
- 5.5. Paper
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country
- 5.6. Textile
- 5.6.1. Key market trends, growth factors and opportunities
- 5.6.2. Market size and forecast, by region
- 5.6.3. Market share analysis by country
- 5.7. Others
- 5.7.1. Key market trends, growth factors and opportunities
- 5.7.2. Market size and forecast, by region
- 5.7.3. Market share analysis by country
CHAPTER 6: MICROBIAL CELLULOSE MARKET, BY REGION
- 6.1. Overview
- 6.1.1. Market size and forecast By Region
- 6.2. North America
- 6.2.1. Key trends and opportunities
- 6.2.2. Market size and forecast, by Growth Medium
- 6.2.3. Market size and forecast, by Application
- 6.2.4. Market size and forecast, by country
- 6.2.4.1. U.S.
- 6.2.4.1.1. Key market trends, growth factors and opportunities
- 6.2.4.1.2. Market size and forecast, by Growth Medium
- 6.2.4.1.3. Market size and forecast, by Application
- 6.2.4.2. Canada
- 6.2.4.2.1. Key market trends, growth factors and opportunities
- 6.2.4.2.2. Market size and forecast, by Growth Medium
- 6.2.4.2.3. Market size and forecast, by Application
- 6.2.4.3. Mexico
- 6.2.4.3.1. Key market trends, growth factors and opportunities
- 6.2.4.3.2. Market size and forecast, by Growth Medium
- 6.2.4.3.3. Market size and forecast, by Application
- 6.3. Europe
- 6.3.1. Key trends and opportunities
- 6.3.2. Market size and forecast, by Growth Medium
- 6.3.3. Market size and forecast, by Application
- 6.3.4. Market size and forecast, by country
- 6.3.4.1. Germany
- 6.3.4.1.1. Key market trends, growth factors and opportunities
- 6.3.4.1.2. Market size and forecast, by Growth Medium
- 6.3.4.1.3. Market size and forecast, by Application
- 6.3.4.2. France
- 6.3.4.2.1. Key market trends, growth factors and opportunities
- 6.3.4.2.2. Market size and forecast, by Growth Medium
- 6.3.4.2.3. Market size and forecast, by Application
- 6.3.4.3. Italy
- 6.3.4.3.1. Key market trends, growth factors and opportunities
- 6.3.4.3.2. Market size and forecast, by Growth Medium
- 6.3.4.3.3. Market size and forecast, by Application
- 6.3.4.4. Spain
- 6.3.4.4.1. Key market trends, growth factors and opportunities
- 6.3.4.4.2. Market size and forecast, by Growth Medium
- 6.3.4.4.3. Market size and forecast, by Application
- 6.3.4.5. UK
- 6.3.4.5.1. Key market trends, growth factors and opportunities
- 6.3.4.5.2. Market size and forecast, by Growth Medium
- 6.3.4.5.3. Market size and forecast, by Application
- 6.3.4.6. Rest of Europe
- 6.3.4.6.1. Key market trends, growth factors and opportunities
- 6.3.4.6.2. Market size and forecast, by Growth Medium
- 6.3.4.6.3. Market size and forecast, by Application
- 6.4. Asia-Pacific
- 6.4.1. Key trends and opportunities
- 6.4.2. Market size and forecast, by Growth Medium
- 6.4.3. Market size and forecast, by Application
- 6.4.4. Market size and forecast, by country
- 6.4.4.1. China
- 6.4.4.1.1. Key market trends, growth factors and opportunities
- 6.4.4.1.2. Market size and forecast, by Growth Medium
- 6.4.4.1.3. Market size and forecast, by Application
- 6.4.4.2. India
- 6.4.4.2.1. Key market trends, growth factors and opportunities
- 6.4.4.2.2. Market size and forecast, by Growth Medium
- 6.4.4.2.3. Market size and forecast, by Application
- 6.4.4.3. Japan
- 6.4.4.3.1. Key market trends, growth factors and opportunities
- 6.4.4.3.2. Market size and forecast, by Growth Medium
- 6.4.4.3.3. Market size and forecast, by Application
- 6.4.4.4. South Korea
- 6.4.4.4.1. Key market trends, growth factors and opportunities
- 6.4.4.4.2. Market size and forecast, by Growth Medium
- 6.4.4.4.3. Market size and forecast, by Application
- 6.4.4.5. Australia
- 6.4.4.5.1. Key market trends, growth factors and opportunities
- 6.4.4.5.2. Market size and forecast, by Growth Medium
- 6.4.4.5.3. Market size and forecast, by Application
- 6.4.4.6. Rest of Asia-Pacific
- 6.4.4.6.1. Key market trends, growth factors and opportunities
- 6.4.4.6.2. Market size and forecast, by Growth Medium
- 6.4.4.6.3. Market size and forecast, by Application
- 6.5. LAMEA
- 6.5.1. Key trends and opportunities
- 6.5.2. Market size and forecast, by Growth Medium
- 6.5.3. Market size and forecast, by Application
- 6.5.4. Market size and forecast, by country
- 6.5.4.1. Brazil
- 6.5.4.1.1. Key market trends, growth factors and opportunities
- 6.5.4.1.2. Market size and forecast, by Growth Medium
- 6.5.4.1.3. Market size and forecast, by Application
- 6.5.4.2. South Africa,
- 6.5.4.2.1. Key market trends, growth factors and opportunities
- 6.5.4.2.2. Market size and forecast, by Growth Medium
- 6.5.4.2.3. Market size and forecast, by Application
- 6.5.4.3. Saudi Arabia
- 6.5.4.3.1. Key market trends, growth factors and opportunities
- 6.5.4.3.2. Market size and forecast, by Growth Medium
- 6.5.4.3.3. Market size and forecast, by Application
- 6.5.4.4. Rest of LAMEA
- 6.5.4.4.1. Key market trends, growth factors and opportunities
- 6.5.4.4.2. Market size and forecast, by Growth Medium
- 6.5.4.4.3. Market size and forecast, by Application
CHAPTER 7: COMPETITIVE LANDSCAPE
- 7.1. Introduction
- 7.2. Top winning strategies
- 7.3. Product Mapping of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Top player positioning, 2022
CHAPTER 8: COMPANY PROFILES
- 8.1. Borregaard AS
- 8.1.1. Company overview
- 8.1.2. Key Executives
- 8.1.3. Company snapshot
- 8.1.4. Operating business segments
- 8.1.5. Product portfolio
- 8.1.6. Business performance
- 8.2. Axcelon Biopolymers Corporation
- 8.2.1. Company overview
- 8.2.2. Key Executives
- 8.2.3. Company snapshot
- 8.2.4. Operating business segments
- 8.2.5. Product portfolio
- 8.3. BOWIL Biotech Sp. z o.o.
- 8.3.1. Company overview
- 8.3.2. Key Executives
- 8.3.3. Company snapshot
- 8.3.4. Operating business segments
- 8.3.5. Product portfolio
- 8.4. Merck KGaA
- 8.4.1. Company overview
- 8.4.2. Key Executives
- 8.4.3. Company snapshot
- 8.4.4. Operating business segments
- 8.4.5. Product portfolio
- 8.4.6. Business performance
- 8.5. BacPolyZyme
- 8.5.1. Company overview
- 8.5.2. Key Executives
- 8.5.3. Company snapshot
- 8.5.4. Operating business segments
- 8.5.5. Product portfolio
- 8.6. Ashland
- 8.6.1. Company overview
- 8.6.2. Key Executives
- 8.6.3. Company snapshot
- 8.6.4. Operating business segments
- 8.6.5. Product portfolio
- 8.6.6. Business performance
- 8.6.7. Key strategic moves and developments
- 8.7. HYSSES
- 8.7.1. Company overview
- 8.7.2. Key Executives
- 8.7.3. Company snapshot
- 8.7.4. Operating business segments
- 8.7.5. Product portfolio
- 8.8. BIOESQUE
- 8.8.1. Company overview
- 8.8.2. Key Executives
- 8.8.3. Company snapshot
- 8.8.4. Operating business segments
- 8.8.5. Product portfolio
- 8.9. HBBE
- 8.9.1. Company overview
- 8.9.2. Key Executives
- 8.9.3. Company snapshot
- 8.9.4. Operating business segments
- 8.9.5. Product portfolio
- 8.10. HNB BIO CO., LTD.
- 8.10.1. Company overview
- 8.10.2. Key Executives
- 8.10.3. Company snapshot
- 8.10.4. Operating business segments
- 8.10.5. Product portfolio